179 related articles for article (PubMed ID: 11366245)
1. Antiretroviral therapy in the experienced patient.
Gallant JE
Hopkins HIV Rep; 1999 Mar; 11(2):1, 4, 9, 16. PubMed ID: 11366245
[TBL] [Abstract][Full Text] [Related]
2. Treatment of the naive patient.
Bartlett JG
Hopkins HIV Rep; 1999 Mar; 11(2):1, 10-1. PubMed ID: 11366244
[TBL] [Abstract][Full Text] [Related]
3. Selected highlights from the 5th Conference on Retroviruses and Opportunistic Infections.
Bartnof HS
BETA; 1998 Apr; ():49-56. PubMed ID: 11365269
[TBL] [Abstract][Full Text] [Related]
4. Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker.
Follansbee S; Deeks S; Bartnoff H
Newsline People AIDS Coalit N Y; 1998 Mar; ():7-14. PubMed ID: 11367453
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy: rehashes, leftovers, and a pinch of new data.
Gallant JE
Hopkins HIV Rep; 1998 Nov; 10(6):1, 4, 9-11. PubMed ID: 11366128
[TBL] [Abstract][Full Text] [Related]
6. A new approach to initial antiretroviral therapy: protease-sparing combination regimens.
Hanna L
BETA; 1998 Oct; ():9-13. PubMed ID: 11365999
[TBL] [Abstract][Full Text] [Related]
7. What's new and what's next.
Fakuda D
Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
[TBL] [Abstract][Full Text] [Related]
8. Drugs of tomorrow.
Posit Aware; 1998; 9(3):27-31. PubMed ID: 11365484
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral update from the Interscience Conference on Antimicrobial Agents and Chemotherapy.
Newsline People AIDS Coalit N Y; 1998 Dec; ():16-8. PubMed ID: 11367083
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy for previously treated patients.
Montaner JS; Mellors JW
N Engl J Med; 2001 Aug; 345(6):452-5. PubMed ID: 11496858
[No Abstract] [Full Text] [Related]
11. Protease inhibitor failure trial: combination 1592, 141W94, and efavirenz.
AIDS Treat News; 1997 Dec; (No 284):4. PubMed ID: 11364914
[TBL] [Abstract][Full Text] [Related]
12. The latest antiviral news.
Vazquez E
Posit Aware; 1999; 10(2):44. PubMed ID: 11366851
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches for the treatment of HIV.
Arroyo HT
Newsline People AIDS Coalit N Y; 1998 Mar; ():16-7. PubMed ID: 11367450
[TBL] [Abstract][Full Text] [Related]
14. A new HAART on the horizon says the proof is in the potency.
AIDS Alert; 1999 Apr; 14(4):37-9. PubMed ID: 11366218
[TBL] [Abstract][Full Text] [Related]
15. What's new, what's next?
Elwell A
Posit Dir News; 1999; 11(1):1, 3-13. PubMed ID: 11366098
[TBL] [Abstract][Full Text] [Related]
16. New drugs in development.
Proj Inf Perspect; 1998 Sep; (25):8. PubMed ID: 11365851
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.
Wasmuth JC; Herhaus C; Römer K; Salzberger B; Kaiser R; Schliefer K; Voigt E; Rockstroh JK
AIDS; 2002 May; 16(7):1077-8. PubMed ID: 11953478
[No Abstract] [Full Text] [Related]
18. Preparing for the future.
Cox S
Posit Aware; 1997; 8(2):10-1. PubMed ID: 11364448
[TBL] [Abstract][Full Text] [Related]
19. [HIV infections: mortality reduced only in developed countries].
Wehr A
Dtsch Med Wochenschr; 1999 May; 124(18):A8-9. PubMed ID: 10356577
[No Abstract] [Full Text] [Related]
20. The medical merry-go-round: drugs for 1998 are new but not novel.
Gilden D
GMHC Treat Issues; 1997-1998 Winter; 12(1):18-25. PubMed ID: 11364984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
